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Phospholipase A2 mediates immediate early genes in cultured is excreted by the kidney [1]. This dicarboxylate was long
renal epithelial cells: Possible role of lysophospholipid. considered to be an inert metabolic byproduct; however,
Background. Exposure to high levels of oxalate induces oxi- recent studies from our laboratory [2–4] and those ofdant stress in renal epithelial cells and produces diverse changes
others [5–7] demonstrated that oxalate exposure can in-in cell function, ranging from cell death to cellular adaptation,
duce oxidant stress, leading to death of renal epithelialas evidenced by increased DNA synthesis, cellular proliferation,
and induction of genes associated with remodeling and repair. cells. Not all cells die in response to oxalate, however,
These studies focused on cellular adaptation to this oxidant even at high oxalate concentrations. Rather, the majority
stress, examining the manner by which oxalate exposure leads of cells exhibit adaptive responses, including increasedto increased expression of immediate early genes (IEGs). Spe-
expression of immediate early genes (IEGs; for example,cifically, our studies assessed the possibility that oxalate-induced
c-jun, egr-1, c-myc), increased DNA synthesis/increasedchanges in IEG expression are mediated by phospholipase A2
(PLA2), a common pathway in cellular stress responses. cellular proliferation [8, 9], and increased expression of
Methods. Madin-Darby canine kidney (MDCK) cells were genes associated with remodeling and repair (for exam-
exposed to oxalate in the presence or absence of PLA2 inhibitors: ple, osteopontin and clusterin) [10]. The present studiesmepacrine and arachidonyl trifluoromethyl ketone (AACOCF3).
examined the mechanisms underlying these adaptive re-Expression of IEG (c-jun, egr-1, and c-myc) mRNA was as-
sponses to oxalate, focusing on biochemical pathwayssessed by Northern blot analysis. PLA2 activity was determined
by measuring the release of [3H]arachidonic acid (AA) from that link oxalate exposure to increased expression of
prelabeled cells. IEGs, since these gene products coordinate a variety of
Results. Oxalate exposure (1 to 1.5 mmol/L) induced time- and cellular responses, including entry into the cell cycle (andconcentration-dependent increases in IEG mRNA. Treatment
hence DNA synthesis and proliferation) and/or pro-with mepacrine resulted in a 75 to 113% reduction of oxalate-
induced c-jun, egr-1, and c-myc mRNA, while AACOCF3 grammed cell death [11–13].
caused a 41 to 46% reduction of oxalate-induced c-jun and One biochemical pathway that has been implicated in
egr-1 mRNA. Of the two major byproducts of PLA2, only cellular responses to stress involves phospholipase A2lysophosphatidylcholine (20 mmol/L) increased c-jun and egr-1
(PLA2), a family of enzymes that hydrolyzes membranemRNA. In contrast, AA (25 mmol/L) attenuated the oxalate-
phospholipids, producing active byproducts [arachidonicinduced increase in c-jun and egr-1 mRNA, presumably by
inhibiting PLA2 activity. acid (AA) and lysophospholipids] that directly or indi-
Conclusions. These findings suggest that PLA2 plays a major rectly alter a number of cell functions [14–16], including
role in oxalate-induced IEG expression in renal epithelial cells the transcription of specific genes [17–20]. The PLA2and that lysophospholipids might be a possible lipid mediator
pathway is activated in various types of renal injury, in-in this pathway.
cluding those involving increased oxidant stress [21, 22].
Moreover, recent studies in our laboratory demonstrated
that oxalate exposure can increase AA release from cul-Oxalate, a common constituent and a major risk factor
tured renal epithelial cells by the action of PLA2 [23].for kidney stones, is an end product of metabolism that
Therefore, it is possible that this enzyme mediates the
observed functional changes in these cells following oxa-
late exposure. The present studies assessed this possibilityKey words: MDCK cells, arachidonic acid, oxalate, kidney stones, pro-
grammed cell death, cell stress response. by determining whether agents that block PLA2 activity
will also block oxalate-induced changes in IEG expres-Received for publication September 14, 1999
sion in renal epithelial cells and by determining whetherand in revised form January 18, 2000
Accepted for publication March 13, 2000 PLA2 byproducts (AA and/or lysophospholipids) can
mimic the effects of oxalate on IEG expression. TheÓ 2000 by the International Society of Nephrology
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results from these studies support the role of PLA2 in the program [24]. Stock solutions (10 mmol/L) of AA, LPC,
and AACOCF3 were prepared in dimethyl sulfoxide.oxalate-induced increase in IEG expression, and suggest
the involvement of lysophospholipid, one of the byprod- Stock solutions (10 mmol/L) of dibucaine and A23187
were prepared in ethanol. Drugs were diluted to obtainucts of PLA2 activity, as a mediator of this response.
concentrations as indicated in Table 1 and the figure
legends. Corresponding vehicle controls were included
METHODS
for comparison. In the experiments testing the effect of
Materials PLA2 inhibitors, cells were incubated with inhibitors for
30 minutes before and during oxalate exposure.Dulbecco’s modified Eagle medium (DMEM) and
antibiotics (penicillin/streptomycin) were obtained from
Northern blot analysisGIBCO BRL (Grand Island, NY, USA). Fetal bovine
serum (FBS), AA, and mepacrine were purchased from Total RNA was extracted using RNeasy Mini Kits
(Qiagen, Valencia, CA, USA) according to the manufac-Sigma Chemical (St. Louis, MO, USA). Arachidonyl
trifluoromethyl ketone (AACOCF3) was from Biomol turer’s directions and fractionated on denaturing 1%
agarose gels (10 mg total RNA per lane). Separated RNAResearch Laboratories (Plymouth, PA, USA). [5,6,8,9,11,
12,14,15-3H(N)]AA ([3H]AA; 60 to 100 Ci/mmol) and was transferred to nitrocellulose membranes (Hybond-C
extra; Amersham Pharmacia Biotech, Piscataway, NJ,[32P]dCTP were obtained from DuPont New England
Nuclear (Cambridge, MA, USA). Lysophosphatidyl- USA) by capillary blotting and fixed by baking at 808C
for two hours. Blots were prehybridized for at least twocholine (LPC; 1-palmitoyl-2-hydroxy-sn-glycero-3-phos-
phocholine) and lysophosphatidic acid (LPA; 1-acyl-2- hours at 428C, hybridized overnight to [32P]dCTP-labeled
cDNA probes prepared by random primer labeling, andhydroxy-sn-glycero-3-phosphate) were from Avanti Po-
lar Lipids (Birmingham, AL, USA). All other chemicals then washed stringently prior to image analysis. The
murine c-jun cDNA probe (a gift from Dr. Paul Dobner,were of highest grade available.
University of Massachusetts Medical School, Worcester,
Cell culture MA, USA) hybridized with two mRNAs (2.7 and 3.2 kb)
in MDCK cells. The murine egr-1 cDNA probe (obtainedMadin-Darby canine kidney (MDCK) cells (CCL 34,
passages 53 to 90) were obtained from the American from ATCC) was hybridized with a 3.3 kb mRNA. The
murine c-myc cDNA probe (a gift from Dr. Nancy Phil-Type Culture Collection (ATCC; Rockville, MD, USA)
and were maintained in DMEM supplemented with 2% lips, University of Massachusetts Medical School) was
hybridized with a 2.3 kb mRNA. DNA-RNA hybridsFBS, 4.5 g/L d-glucose, and antibiotics (100 U/mL
penicillin 1 100 mg/mL streptomycin) at 378C under 5% were detected by phosphorimage analysis, using a Bio-
Rad Molecular Imager (Hercules, CA, USA). Quantita-CO2/95% air. In preparation for mRNA experiments,
cells were plated in six-well culture plates, grown to 80% tive analysis was performed using Multi Analyst program
(Bio-Rad). All estimates of mRNA abundance were cor-confluence, and then made quiescent by incubation in
fresh DMEM containing 0.25% FBS for 48 hours. Cells rected for differences in RNA loading and transfer effi-
ciency by normalization to the abundance of 18S RNAreached confluence during this period, although growth
rates were slowed markedly. Such conditions also re- on the blot, which was determined by scanning densi-
tometry of the photographic negative of the ethidium-duced the basal expression of IEG mRNA, which is
normally high in serum-containing media, such that we bromide–stained RNA. All experiments were performed
at least three times.could reliably detect an induction of IEG in response to
various stimuli. For studies on the release of AA, cells
Measurement of arachidonic acid releasewere grown to approximately 80% confluence in 12-well
culture plates prior to labeling with [3H]AA. [3H]arachidonic acid release was determined as de-
scribed previously [23]. Subconfluent cultures of MDCK
Experimental protocol cells in 12-well plates were incubated for 12 to 18 hours
with 0.2 mCi/mL (2 to 3.3 nmol/L) of [3H]AA in serum-Various treatments were performed by exchanging the
medium for serum-free DMEM containing the agent of free DMEM, a period that allowed cells to reach conflu-
ence and to incorporate 94.0 6 0.5% of added radioactivity.interest and continuing the incubation for a predeter-
mined period at 378C under an atmosphere of 5% CO2/ The cells were then washed twice with phosphate-buffered
saline (PBS; pH 7.4) and once with DMEM containing95% air. Where indicated, sodium oxalate was added at
a concentration of 1 or 1.5 mmol/L (total), which pro- 0.2% fatty acid-free bovine serum albumin (BSA) prior
to the addition of various agents. Cells were then exposedvides free oxalate levels of 350 and 550 mmol/L, and
produces relative super-saturation levels (RSS) for cal- to the agent of interest for a predetermined time. The
medium was collected and centrifuged to remove anycium oxalate of 24.9 and 35.9, respectively. Estimates of
free oxalate and RSS were obtained using the EQUIL floating cells, and the radioactivity in 400 mL of superna-
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Table 1. Effect of exogenous arachidonic acid (AA) on oxalate- and A23187-induced immediate early genes (IEG; c-jun and egr-1) mRNA
and [3H]AA release in MDCK cells
mRNA abundancea (% control)
[3H]AA releasec
Treatment c-jun egr-1 % control
Control 1 vehicle 100.0 100.0 100.0611.1
AA 25 lmol/L 79.9610.6 74.263.8b 129.968.2
Oxalate 1 mmol/L 1 vehicle 326.0660.2 183.9616.7 256.1629.5
AA 25 lmol/L 177.8644.5b 60.9625.1 129.1610.9d
A23187 3 lmol/L 1 vehicle 647.56209.6 270.3611.8 468.2652.0
AA 25 lmol/L 291.16151.1 72.7629.1 304.9614.7e
aQuiescent cultures of MDCK cells were treated with oxalate (1 mmol/L) or A23187 (3 mmol/L) for 2 hr in the presence or absence of AA (25 mmol/L). Total
RNA was extracted and subjected to Northern blot analysis for c-jun and egr-1. The abundance of mRNA was quantified and expressed relative to 18S RNA
abundance. All values were then normalized relative to control for each experiment. Data are presented as means 6 SE of 3 independent experiments. Exogenous
AA decreased control and oxalate- and A23187-induced increases in c-jun and egr-1 mRNA, although the differences were not significant by one-way ANOVA
performed on 6 treatment groups
bP , 0.05 vs. corresponding vehicle using a Student’s t-test for paired data
cSubconfluent cultures of MDCK cells were incubated for 12 to 18 hours with 0.2 mCi/mL (2 to 3.3 nmol/L) of [3H]AA in serum-free DMEM. After labeling, cells
were washed twice with PBS and once with DMEM containing 0.2% fatty acid-free BSA. Cells were then exposed to oxalate (1 mmol/L) or A23187 (3 mmol/L).
After 1 hour, the medium was collected, centrifuged, and counted for [3H]AA released by cells, and the adherent cells were solubilized with 1% Triton X-100 and
counted to determine [3H]AA associated with cells. The release of [3H]AA into the medium was expressed as a percentage of total incorporated (cell-associated
plus released). All of the values were then normalized relative to controls for each experiment. Simultaneous addition of AA significantly decreased oxalate- and
A23187-induced [3H]AA release. Data are means 6 SE of 3 independent experiments performed in triplicate
dP , 0.01
eP , 0.05 vs. corresponding vehicle using a Student’s t-test for unpaired data
tant was measured in a liquid scintillation counter (LS cells after a one-, two-, or four-hour exposure to oxalate.
6500; Beckman Instruments, Fullerton, CA, USA). Ad- As shown in the representative Northern blot in Figure
herent cells were solubilized with 1 mL of 1% Triton X- 1, exposure to oxalate (1 to 1.5 mmol/L) increased the
100, and the radioactivity in 400 mL of the cell lysate expression of c-jun and egr-1 mRNA at one, two, and
was determined. The release of [3H]AA into the medium four hours, and c-myc mRNA at four hours. Quantitative
was expressed as a percentage of total label incorporated analyses of mRNA data from at least three experiments
(cell-associated plus released). of this type are shown in Figure 2. Note that the oxalate-
induced increase in c-jun expression was maximal at two
Statistical analyses hours, with 1 and 1.5 mmol/L oxalate producing 1.9- and
Statistical evaluation of the effects of various agents on 3.0-fold increases, respectively. Egr-1 mRNA induction
IEG expression was performed using one-way analysis of was also maximal at the same time, with 1 and 1.5 mmol/L
variance and the SuperANOVATM software package oxalate producing 2.2- and 3.4-fold increases, respec-
(Abacus Concepts Inc., Berkeley, CA, USA). Prior to tively. Oxalate-induced changes in c-myc expression
data analysis, mRNA data were corrected for 18S RNA were only apparent at four hours, however, with 1 and
abundance. Within each Northern blot, data were nor- 1.5 mmol/L oxalate producing 1.6- and 2.5-fold increases,
malized to their respective control group (that is, cells respectively. Thus, oxalate exposure induced time- and
in serum-free media for 1, 2, or 4 h). Variance around concentration-dependent increases in c-jun, egr-1, and
the arithmetic means was found not to be normally dis- c-myc mRNA in MDCK cells. Based on these findings,
tributed; therefore, data were transformed to their natu- subsequent experiments examined c-jun and egr-1 ex-
ral logarithms prior to statistical analysis to stabilize this pression at two hours and c-myc expression at four hours
variance [25]. Comparisons among treatment groups after the addition of 1 mmol/L oxalate, a concentration
were made using the Duncan multiple comparison proce- that elicits submaximal induction of each gene.
dure [26]. Following statistical analyses, logarithmically
transformed data were converted back to their antiloga- PLA2 inhibitors reduce oxalate-induced
rithms and then plotted as histograms using arithmetic IEG expression
scales. [3H]AA release data were normalized relative to
Previous studies demonstrated that oxalate exposurecontrol for each experiment, and statistical evaluation
increases [3H]AA release from MDCK cells by a processwas performed using Student’s t-test for unpaired data.
dependent on PLA2 and suggested that this enzyme is
responsible, at least in part, for oxalate toxicity [23]. To
RESULTS determine whether PLA2 is also involved in regulating
Oxalate increases expression of immediate early genes gene expression in response to oxalate, we determined
in MDCK cells whether treatment with PLA2 inhibitors would block
the oxalate-induced changes in IEG expression. TwoThese studies examined the expression of three IEGs:
c-jun, egr-1, and c-myc, in quiescent cultures of MDCK different inhibitors were used, mepacrine, a general
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Fig. 1. Northern blot analysis of total RNA for immediate early genes (IEGs; c-jun, egr-1 and c-myc) following exposure of MDCK cells to
oxalate, lysophosphatidylcholine (LPC), and lysophosphatidic acid (LPA). Quiescent cultures of MDCK cells were exposed to oxalate (1 to 1.5
mmol/L), LPC (20 mmol/L), or LPA (20 mmol/L) for various times, as indicated at the top of the panel. Total RNA was extracted and fractionated
on a denaturing 1% agarose gel (10 mg total RNA per lane) and then transferred to nitrocellulose membrane. The blot was hybridized with
[32P]cDNA probes for c-jun, egr-1, and c-myc. Oxalate exposure induced time- and concentration-dependent increases in three IEGs. LPC also
increased c-jun and egr-1 mRNA, while LPA did not. Ethidium-bromide stained 18S RNA from the same blot is also shown. The blot is representative
of four independent experiments.
PLA2 inhibitor, and AACOCF3, a selective inhibitor for induced increases in c-jun and egr-1 mRNA by 41 to
46%, while treatment with mepacrine reduced oxalatecytosolic PLA2 (cPLA2) [27], and cells were incubated
with concentrations of inhibitors known to inhibit oxalate- effects on all three IEGs by 75 to 113% (Fig. 4). These
findings suggest that PLA2 plays a role in oxalate-inducedinduced [3H]AA release in this cell line [23]. As shown
in the representative Northern blot in Figure 3, both IEG expression in MDCK cells.
AACOCF3 (10 mmol/L) and mepacrine (25 mmol/L)
PLA2 inhibitors also reduce A23187-inducedmarkedly reduced oxalate-induced c-jun and egr-1 mRNA
IEG expressionexpression at two hours. AACOCF3 was not used in
studies on c-myc expression, since this gene is induced To obtain further evidence that PLA2 plays a role in
IEG expression, we examined IEG expression after expo-more slowly in MDCK cells (4 hours vs. 1 to 2 hours for
c-jun and egr-1; Fig. 1) and since AACOCF3 is reportedly sure to A23187, a known activator of cPLA2 in MDCK
cells [28, 29]. As shown in Figures 3 and 4, treatment ofconverted to an inactive byproduct [AACH(OH)CF3]
on prolonged incubation with living cells [27]. Thus, stud- the cells with 3 mmol/L A23187, a concentration that
increases [3H]AA release from MDCK cells markedlyies on c-myc expression employed only mepacrine as a
PLA2 inhibitor. The results showed that treatment with increased the expression of all three IEGs (Table 1),
indicating that the cPLA2-activating agent, A23187, canmepacrine abolished the oxalate-induced increase in
c-myc mRNA at four hours. Neither AACOCF3 alone mimic oxalate actions on IEG expression. Furthermore,
the effects of A23187 on IEG mRNA, like the effectsnor mepacrine alone had any effect on basal expression
of the three IEGs. Quantitative analyses demonstrated of oxalate, were attenuated by the PLA2 inhibitors
AACOCF3 and mepacrine. These findings support thethat treatment with AACOCF3 attenuated the oxalate-
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treatment of MDCK cells with AA (25 mmol/L) did not
increase c-jun and egr-1 mRNA; rather, it reduced basal
levels and markedly attenuated both the oxalate-induced
and the A23187-induced increases in c-jun and egr-1
mRNA (Table 1). This attenuation appeared to reflect
feedback inhibition of PLA2, as evidenced by the finding
that the addition of exogenous AA (25 mmol/L) signifi-
cantly reduced [3H]AA release from prelabeled cells (Ta-
ble 1). Thus, although oxalate-induced changes in IEG
appear to involve PLA2 activity, it does not seem likely
that the effects are mediated by AA. Subsequent studies
examined other possible byproducts of PLA2 activity.
LPC mimics oxalate actions on IEG expression
Since lysophospholipids are the other byproducts of
PLA2, we determined whether oxalate-induced changes
in IEG could be mimicked by one or more members of
this class of lipids. Studies focused initially on the possi-
ble involvement of LPC, since phosphatidylcholine, the
lipid precursor for LPC, is the most common phospho-
lipid in cell membranes, and since studies in other sys-
tems had demonstrated that LPC (and LPA, which can
be derived from LPC) can elicit various changes in cellular
function, including changes in gene expression [32–38].
Thus, we examined the effect of exogenous LPC and
LPA on IEG mRNA expression in MDCK cells. As
shown in Figures 1 and 2, LPC (20 mmol/L) increased
c-jun and egr-1 expression at one and two hours to the
same extent as produced by oxalate. Unlike oxalate, how-
ever, LPC failed to increase c-myc mRNA expression.
Fig. 2. Quantitative analysis of the effects of oxalate, LPC, and LPA LPA (20 mmol/L) had no effect on mRNA levels for any
on IEG mRNA expression. Symbols are: (h) control; ( ) oxalate 1.0
of the IEG, irrespective of the time point examined.mmol/L; ( ) oxalate 1.5 mmol/L; ( ) LPC 20 mmol/L; ( ) LPA 10
mmol/L. MDCK cells were treated as in Figure 1. Abundance of c-jun, These results suggest that LPC may serve as a mediator
egr-1, and c-myc mRNAs was corrected for 18S RNA abundance. All of oxalate-induced expression of c-jun and egr-1, althoughvalues were then normalized relative to the control value (serum-free
regulation of c-myc expression appears to involve a dif-DMEM) at each time point. Oxalate-induced increases in c-jun and
egr-1 mRNAs were maximum at two hours, whereas increased c-myc ferent mechanism.
expression was apparent only at four hours. LPC-induced increases in To examine the involvement of LPC in oxalate actionsc-jun and egr-1 mRNAs were comparable at one and two hours. LPC
further, we looked at the effect of concomitant additionhad no effect on c-myc mRNA. LPA had no effect on any IEG mRNA.
Data are plotted as the mean plus one standard error of the mean for of oxalate and LPC on IEG mRNA. As shown in Figure
three or four independent experiments. *P , 0.05 vs. control; **P , 5, treatment of MDCK cells with a combination of oxa-0.01 vs. control.
late (1.5 mmol/L) plus LPC (20 mmol/L) failed to pro-
duce a further increase in c-jun and egr-1 mRNA over
that seen with oxalate alone or with LPC alone. Note
contention that PLA2 activity plays a role in the induction that either stimulus alone did not produce a maximum
of c-jun, egr-1, and c-myc in response to oxalate. induction of the IEGs, since the addition of A23187 (5
mmol/L) resulted in a greater increase in c-jun and egr-1
Exogenous arachidonic acid fails to mimic oxalate mRNA than was observed with either oxalate or LPC
actions on IEG expression alone (Table 1). These findings suggest that oxalate and
The finding that PLA2 activity mediates oxalate-induced LPC use a common biochemical pathway.
IEG expression prompted us to examine which of the
PLA2 products, AA or lysophospholipid, mediates oxa-
DISCUSSIONlate-induced IEG expression. Since AA and its metabo-
The present studies on renal epithelial cells derivedlites have been demonstrated to induce IEG in different
from the distal kidney of the dog (MDCK cells) are thecell lines [17–19], we first assessed the effect of exogenous
AA on IEG mRNA. In contrast to our expectation, first to demonstrate a causal link between PLA2 activity
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Fig. 3. Northern blot analysis of total RNA
for IEGs (c-jun, egr-1, and c-myc) following
exposure of MDCK cells to oxalate or calcium
ionophore in the presence or absence of phos-
pholipase A2 (PLA2) inhibitors. Quiescent cul-
tures of MDCK cells were pretreated with
either vehicle, AACOCF3 (10 mmol/L), or
mepacrine (25 mmol/L) for 30 minutes and
then exposed to oxalate (1 mmol/L) or A23187
(3 mmol/L) for the indicated times. Total RNA
was extracted and subjected to Northern blot
analysis for c-jun, egr-1, and c-myc. Note that
both inhibitors markedly reduced oxalate- and
A23187-induced c-jun and egr-1 expression at
two hours and that c-myc induction at four
hours was also abolished by mepacrine. The
blot is representative of four independent ex-
periments.
and induction of several IEGs (c-jun, egr-1 and c-myc) MDCK cells. Thus, the response of MDCK cells to oxa-
late resembles the response to other agents that modu-following oxalate exposure. These studies also provide
evidence suggesting that the lipid byproduct that mediates late IEG expression via pathways involving PLA2 [17–20].
Many different forms of mammalian PLA2 have beenthe observed changes in gene expression is a lysophospho-
lipid rather than AA. Since IEG expression in turn regu- identified, including secretory PLA2 (sPLA2), cPLA2, and
calcium-independent PLA2 (iPLA2). The form of PLA2lates the transcription of other genes that are involved
in the adaptation to cellular stress, these findings provide that is involved in different conditions can vary, depending
on the cell type involved, the type of stimulus applied,a possible mechanism whereby oxalate exposure leads
to activation of cellular processes responsible for remod- and/or the nature of the pathology [14, 15]. The PLA2
inhibitors used in this study showed different inhibitoryeling, repair, and replacement of renal cells. The conclu-
sion that PLA2 mediates oxalate-induced IEG mRNA potency on oxalate-induced IEG expression. Mepacrine,
a “generic” inhibitor that inhibits all isoforms of PLA2,in MDCK cells is supported by several lines of evidence.
For one, the effects of oxalate on IEG expression were blocked oxalate-induced IEG expression to a greater ex-
tent than AACOCF3, an inhibitor selective for cPLA2 (75markedly attenuated by the PLA2 inhibitors mepacrine
and AACOCF3. Second, A23187, an agent that stimulates to 113% vs. 41 to 46%, respectively). This concentration
of AACOCF3 completely abolished the oxalate-inducedcPLA2 in MDCK cells [28, 29], mimicked oxalate actions
on IEG expression, while the induction of IEG by A23187 [3H]AA release from MDCK cells, however. Thus, it is
possible that oxalate actions by other PLA2 isozymeswas also attenuated by PLA2 inhibitors. Third, LPC,
a byproduct of PLA2 action on membranes, increased and/or that these cells express other isoforms of cPLA2
that are resistant to AACOCF3 [30, 31]. The relativethe expression of two IEG mRNAs, c-jun and egr-1, in
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Fig. 5. Effect of simultaneous addition of oxalate and LPC on c-jun
and egr-1 mRNA expression in MDCK cells. Quiescent cultures of
MDCK cells were exposed for two hours to oxalate (1.5 mmol/L),
LPC (20 mmol/L), or oxalate (1.5 mmol/L) 1 LPC (20 mmol/L). The
abundance of c-jun and egr-1 mRNAs was corrected for 18S RNA
abundance. All values were then normalized relative to the control
value. Data for mRNA abundance from selected treatment groups in
Figure 2 were replotted here, along with data from cultures exposed
to a combination of oxalate and LPC. Data are plotted as the mean
plus one standard error of the mean for three to seven independent
experiments. **P , 0.01 vs. control.
AA and its metabolites and recent evidence that these
compounds can modulate gene expression (including the
expression of several IEG) and the activity of transcrip-
Fig. 4. Quantitative analysis of the effects of PLA2 inhibitors on the tion factors such as activating protein (AP-1) and nuclearinduction of IEG mRNAs by oxalate or calcium ionophore. MDCK cells
factor-kB (NF-kB) [17–20] led us to predict that AAwere treated as in Figure 3. Symbols are: (h) vehicle; ( ) AACOCF3;
( ) mepacrine. Abundance of c-jun, egr-1, and c-myc mRNAs was would mediate oxalate actions in MDCK cells. However,
corrected for 18S RNA abundance. All values were then normalized the present studies showed that exogenous AA (25relative to the control value. Treatment with AACOCF3 attenuated the
mmol/L) markedly reduced basal expression of c-jun andoxalate-induced increases in c-jun and egr-1 mRNA by 41 to 46%, while
treatment with mepacrine reduced oxalate effects on all three IEGs by egr-1 mRNA and attenuated the oxalate- and A23187-
75 to 113%. Data were plotted as the mean plus one standard error of induced changes in these gene products. The finding thatthe mean for three to four independent experiments. *P , 0.05 vs. control;
exogenous AA also inhibited oxalate- and ionophore-**P , 0.01 vs. control; †P , 0.05 vs. corresponding vehicle (oxalate or
A23187); ††P , 0.01 vs. corresponding vehicle (oxalate or A23187). induced [3H]AA release from MDCK cells suggests that
AA elicits a product inhibition of PLA2. This effect re-
sembles the response of rat proximal tubules in which
the addition of somewhat higher concentrations of AAsensitivity of other isoforms of cPLA2 to AACOCF3 has
(.100 mmol/L) inhibited PLA2 activity [39].not been established.
The possibility that LPC may serve as a signal for theThe finding that oxalate actions on c-jun and egr-1
regulation of gene expression has been suggested in aexpression could be mimicked by LPC but not by AA
was somewhat surprising. The long history of studies on number of other studies on growth factor actions [32–38,
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40]. Three lines of evidence support a role of LPC as a other cellular actions of oxalate. Further insights as to
signal for oxalate-induced gene expression in renal epithe- the cellular consequences of oxalate-induced changes in
lial cells. For one, the addition of exogenous LPC mim- phospholipid metabolism may prove useful in understand-
icked the effects of oxalate on c-jun and egr-1 mRNA ing the pathogenesis of kidney diseases associated with
expression. Second, LPC and oxalate appeared to use a excessive oxalate excretion, including primary hyper-
common biochemical pathway, since simultaneous expo- oxaluria, end-stage renal disease, and urolithiasis.
sure to oxalate plus LPC failed to produce a further
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